No link but here is the text:
'Also in the market for fresh equity is Tissue Therapies, which has Morgan seeking to raise $3 million in a placement and another $4 million in an entitlement offer. The offer was priced at a steep 36.5 per cent discount to the 10-day volume weighted average price.'
- Companies and Markets section of AFR